Fact CheckerSign in

NCT05288790RecruitingPhase 2

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Source: ClinicalTrials.gov · Last updated 27 Aug 2026

Brief summary (registry, in English)

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
250 (estimated)
First submitted
28 Feb 2022
Start date
18 Sept 2023
Primary completion date
31 Mar 2027
Lead sponsor
Vanderbilt University Medical Center
Diseases
HIV
NCT number
NCT05288790

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 250
  • From 18 Sept 2023 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Not fluent in English

Who the study is looking for

  • HIV infected

Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.